Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe.
Reinert
Ralf R
RR
Paradiso
Peter
P
Fritzell
Bernard
B
D002986:Clinical Trials as Topic; D017277:Drug Approval; D005060:Europe; D006801:Humans; D007115:Immunization Schedule; D011008:Pneumococcal Infections / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology*
C538862:13-valent pneumococcal vaccine; D022242:Pneumococcal Vaccines